News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,981 Results
Type
Article (17590)
Company Profile (37)
Press Release (263354)
Section
Business (81267)
Career Advice (163)
Deals (12553)
Drug Delivery (22)
Drug Development (37183)
Employer Resources (19)
FDA (5278)
Job Trends (4180)
News (135247)
Policy (10457)
Tag
Academia (639)
Africa (285)
Allergies (20)
Alliances (21896)
Alzheimer's disease (329)
Antibody-drug conjugate (ADC) (26)
Approvals (5253)
Arizona (56)
Artificial intelligence (20)
Asia (17533)
Australia (2605)
Bankruptcy (77)
Best Places to Work (3398)
Biotechnology (31)
Breast cancer (27)
C2C Services and Suppliers (35038)
California (679)
Canada (372)
Cancer (246)
Career advice (139)
CAR-T (28)
Cell therapy (54)
China (45)
Clinical research (29080)
Collaboration (51)
Colorado (23)
Connecticut (26)
COVID-19 (1839)
Cystic fibrosis (28)
Data (174)
Diabetes (27)
Diagnostics (1932)
Earnings (21891)
Europe (41745)
Events (49336)
Executive appointments (64)
FDA (5369)
Florida (75)
Funding (63)
Gene therapy (29)
GLP-1 (135)
Government (1338)
Healthcare (4815)
Hotbed/Location (186187)
Illinois (108)
Indiana (26)
Infectious disease (1849)
Inflammatory bowel disease (38)
Interviews (30)
IPO (4818)
Job creations (880)
Job search strategy (126)
Kansas (39)
Layoffs (76)
Legal (2338)
Liver cancer (25)
Lung cancer (50)
Lymphoma (21)
Manufacturing (26)
Maryland (107)
Massachusetts (515)
Medical device (2669)
Medtech (2669)
Mergers & acquisitions (7753)
Metabolic disorders (69)
Michigan (28)
Minnesota (41)
Multiple sclerosis (25)
Neuroscience (382)
New Jersey (226)
New York (231)
NextGen Class of 2024 (1564)
Non-profit (604)
North Carolina (188)
Northern California (302)
Obesity (31)
Ohio (26)
Opinion (110)
Pennsylvania (162)
People (32768)
Phase I (9721)
Phase II (13454)
Phase III (8896)
Pipeline (70)
Postmarket research (1015)
Preclinical (3446)
Radiopharmaceuticals (56)
Rare diseases (47)
Real estate (1706)
Regulatory (7146)
Research institute (606)
Resumes & cover letters (20)
South America (525)
Southern California (292)
Startups (1885)
Texas (98)
United States (2857)
Vaccines (282)
Washington State (114)
Weight loss (23)
Date
Today (33)
Last 7 days (344)
Last 30 days (985)
Last 365 days (13124)
2024 (9241)
2023 (13809)
2022 (19327)
2021 (22470)
2020 (19460)
2019 (10501)
2018 (7987)
2017 (14299)
2016 (16881)
2015 (21275)
2014 (15972)
2013 (13473)
2012 (13908)
2011 (13590)
2010 (11865)
280,981 Results for "ferring b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Ferring Pharmaceuticals and Posterity Health Launch New Partnership to Activate Men About Their Fertility
Ferring Pharmaceuticals today launched a new Male Fertility program on Ferring’s Fertility Out Loud platform that empowers men to take the initiative to understand their fertility status.
June 20, 2024
·
4 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
Pharm Country
Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
Ferring Pharmaceuticals today announced the presentation of two analyses of data at the American Society of Pain and Neuroscience (ASPN) 2024 Annual Meeting, for SI-6603, an investigational therapy intended to treat radicular leg pain associated with lumbar disc herniation (LDH).
June 24, 2024
·
3 min read
Pharm Country
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.
March 4, 2024
·
3 min read
Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring
Ferring published its 2023 Annual Report showing the company’s annual revenues were €2.2 billion, a decrease of -4% on the previous year at actual exchange rates, but an increase of +1% at constant exchange rates.
April 9, 2024
·
4 min read
Pharm Country
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.
May 29, 2024
·
3 min read
Pharm Country
Ferring Adds Three New Studies to Non-Muscle Invasive Bladder Cancer Clinical Trial Program With ADSTILADRIN® (nadofaragene firadenovec-vncg)
Ferring Pharmaceuticals today announced start up of new studies in the United States (U.S.) for three new ADSTILADRIN in BLadder cancEr (ABLE) clinical trials in patients with non-muscle invasive bladder cancer (NMIBC) with plans to expand select clinical trials outside of the U.S. later this year.
April 16, 2024
·
9 min read
Business
Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”) today announced that it will report its First Quarter 2024 Earnings Results on Wednesday, April 24, 2024, after the Mexican Stock Exchange (BMV) close.
April 4, 2024
·
2 min read
BioCapital
ASRM Announces Historic $5 Million Endowment From Ferring Pharmaceuticals
The American Society for Reproductive Medicine and Ferring Pharmaceuticals announced a historic $5 million endowment from Ferring to ASRM.
October 16, 2023
·
3 min read
Deals
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.
October 2, 2023
·
4 min read
1 of 28,099
Next
